Conor McNamara
Stock Analyst at RBC Capital
(0.83)
# 3,767
Out of 4,868 analysts
123
Total ratings
23.08%
Success rate
-20.14%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Sector Perform | $72 → $63 | $50.14 | +25.66% | 9 | May 8, 2025 | |
| HOLX Hologic | Maintains: Sector Perform | $75 → $70 | $63.97 | +9.43% | 10 | May 2, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $232.00 | +68.97% | 11 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $250.08 | +56.75% | 11 | May 2, 2025 | |
| RGEN Repligen | Maintains: Outperform | $202 → $189 | $117.54 | +60.80% | 11 | Apr 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $24 → $20 | $13.29 | +50.49% | 7 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $651 → $637 | $392.56 | +62.27% | 14 | Apr 24, 2025 | |
| DHR Danaher | Reiterates: Outperform | $250 | $194.44 | +28.57% | 10 | Apr 23, 2025 | |
| ILMN Illumina | Maintains: Outperform | $128 → $112 | $90.26 | +24.09% | 15 | Apr 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $7 → $4 | $1.65 | +142.42% | 3 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $170.98 | +46.80% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $28.33 | +115.32% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $13 | $2.01 | +546.77% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.04 | +130.26% | 4 | Aug 7, 2024 |
Bio-Techne
May 8, 2025
Maintains: Sector Perform
Price Target: $72 → $63
Current: $50.14
Upside: +25.66%
Hologic
May 2, 2025
Maintains: Sector Perform
Price Target: $75 → $70
Current: $63.97
Upside: +9.43%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $232.00
Upside: +68.97%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $250.08
Upside: +56.75%
Repligen
Apr 30, 2025
Maintains: Outperform
Price Target: $202 → $189
Current: $117.54
Upside: +60.80%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $13.29
Upside: +50.49%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $392.56
Upside: +62.27%
Danaher
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $194.44
Upside: +28.57%
Illumina
Apr 8, 2025
Maintains: Outperform
Price Target: $128 → $112
Current: $90.26
Upside: +24.09%
OmniAb
Mar 27, 2025
Maintains: Outperform
Price Target: $7 → $4
Current: $1.65
Upside: +142.42%
Mar 13, 2025
Initiates: Outperform
Price Target: $251
Current: $170.98
Upside: +46.80%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $28.33
Upside: +115.32%
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $2.01
Upside: +546.77%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.04
Upside: +130.26%